Evolent Health, Inc. (EVH)
4.92
+0.03
(+0.61%)
USD |
NYSE |
Aug 26, 12:05
Evolent Health Price to Book Value : 1.447 for Aug. 26, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 25, 2026 | 1.438 |
| August 24, 2026 | 1.388 |
| August 21, 2026 | 1.394 |
| August 20, 2026 | 1.382 |
| August 19, 2026 | 1.347 |
| August 18, 2026 | 1.347 |
| August 17, 2026 | 1.297 |
| August 14, 2026 | 1.376 |
| August 13, 2026 | 1.370 |
| August 12, 2026 | 1.226 |
| August 11, 2026 | 1.206 |
| August 10, 2026 | 1.156 |
| August 07, 2026 | 1.162 |
| August 06, 2026 | 1.056 |
| August 05, 2026 | 0.9057 |
| August 04, 2026 | 0.9145 |
| August 03, 2026 | 0.9233 |
| July 31, 2026 | 0.9086 |
| July 30, 2026 | 0.9351 |
| July 29, 2026 | 0.9703 |
| July 28, 2026 | 1.100 |
| July 27, 2026 | 1.120 |
| July 24, 2026 | 1.241 |
| July 23, 2026 | 1.364 |
| July 22, 2026 | 1.638 |
| Date | Value |
|---|---|
| July 21, 2026 | 1.720 |
| July 20, 2026 | 1.744 |
| July 17, 2026 | 1.708 |
| July 16, 2026 | 1.667 |
| July 15, 2026 | 1.726 |
| July 14, 2026 | 1.820 |
| July 13, 2026 | 1.741 |
| July 10, 2026 | 1.729 |
| July 09, 2026 | 1.656 |
| July 08, 2026 | 1.647 |
| July 07, 2026 | 1.611 |
| July 06, 2026 | 1.688 |
| July 02, 2026 | 1.679 |
| July 01, 2026 | 1.688 |
| June 30, 2026 | 1.594 |
| June 29, 2026 | 1.637 |
| June 26, 2026 | 1.564 |
| June 25, 2026 | 1.427 |
| June 24, 2026 | 1.427 |
| June 23, 2026 | 1.362 |
| June 22, 2026 | 1.271 |
| June 18, 2026 | 1.274 |
| June 17, 2026 | 1.325 |
| June 16, 2026 | 1.334 |
| June 15, 2026 | 1.334 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| DarioHealth Corp. | 0.9582 |
| CompuMed, Inc. | 2.923 |
| Teladoc Health, Inc. | 0.8756 |
| Renalytix Plc | -- |
| Lifestance Health Group, Inc. | 3.168 |
Price to Book Value Related Metrics
| PS Ratio | 0.2640 |
| PEG Ratio | -0.0058 |
| Price to Free Cash Flow | 22.75 |
| Price | 4.92 |
| Earnings Yield | -92.90% |
| Market Cap | 554.41M |
| PEGY Ratio | -0.0058 |